Ha habido 50 transacciones internas recientes registradas para Adicet Bio, Inc. (ACET), incluyendo 31 compras y 17 ventas. El total de compras internas fue valorado en $19.63M y el total de ventas internas en $744.93K.
Internos destacados con actividad reciente incluyen Schor Chen, Harvey Brian Nicholas, Healey Don. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ACET
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-25 |
Schor Chen |
President & CEO |
Concesión de RSU |
468,555 |
$6.81 |
$3.19M |
468,555 |
| 2026-03-25 |
Harvey Brian Nicholas |
Chief Financial Officer |
Concesión de RSU |
43,361 |
$6.81 |
$295.29K |
43,361 |
| 2026-03-25 |
Healey Don |
Chief Technology Officer |
Concesión de RSU |
43,361 |
$6.81 |
$295.29K |
43,361 |
| 2026-03-25 |
Aftab Blake |
Chief Scientific Officer |
Concesión de RSU |
72,555 |
$6.81 |
$494.1K |
72,555 |
| 2026-03-25 |
Maltzman Julia D. |
Chief Medical Officer |
Concesión de RSU |
72,555 |
$6.81 |
$494.1K |
72,555 |
| 2026-01-24 |
Schor Chen |
President & CEO |
Retención Fiscal de RSU |
1,755 |
$8.44 |
$14.81K |
6,820 |
| 2026-01-24 |
Harvey Brian Nicholas |
Chief Financial Officer |
Retención Fiscal de RSU |
546 |
$8.44 |
$4.61K |
5,145 |
| 2026-01-24 |
Healey Don |
Chief Technology Officer |
Retención Fiscal de RSU |
535 |
$8.44 |
$4.52K |
3,452 |
| 2026-01-24 |
Aftab Blake |
Chief Scientific Officer |
Retención Fiscal de RSU |
535 |
$8.44 |
$4.52K |
2,981 |
| 2025-10-08 |
Orbimed Advisors Llc |
10 Percent Owner |
Compra Informativa |
3,500,000 |
$1.00 |
$3.5M |
4,490,254 |
| 2025-06-11 |
Dubin Steve |
Director |
Concesión de RSU |
5,900 |
- |
- |
22,700 |
| 2025-06-11 |
Chodakewitz Jeffrey |
Director |
Concesión de RSU |
5,900 |
- |
- |
17,700 |
| 2025-06-11 |
Sinclair Andrew |
Director |
Concesión de RSU |
5,900 |
- |
- |
17,700 |
| 2025-06-11 |
Klickstein Lloyd |
Director |
Concesión de RSU |
26,400 |
$0.78 |
$20.59K |
26,400 |
| 2025-06-11 |
Peng Katie |
Director |
Concesión de RSU |
5,900 |
- |
- |
11,800 |
| 2025-04-17 |
Grissinger Michael |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-04-17 |
Grissinger Michael |
Director |
Concesión de RSU |
70,200 |
$0.53 |
$36.91K |
70,200 |
| 2025-01-31 |
Schor Chen |
President & CEO |
Concesión de RSU |
763,829 |
$0.89 |
$675.99K |
763,829 |
| 2025-01-31 |
Harvey Brian Nicholas |
Chief Financial Officer |
Concesión de RSU |
324,040 |
$0.89 |
$286.78K |
324,040 |
| 2025-01-31 |
Healey Don |
Chief Technology Officer |
Concesión de RSU |
275,000 |
$0.89 |
$243.38K |
275,000 |
| 2025-01-31 |
Aftab Blake |
Chief Scientific Officer |
Concesión de RSU |
275,000 |
$0.89 |
$243.38K |
275,000 |
| 2025-01-31 |
Maltzman Julia D. |
Chief Medical Officer |
Concesión de RSU |
750,000 |
$0.89 |
$663.75K |
750,000 |
| 2025-01-24 |
Schor Chen |
President & CEO |
Retención Fiscal de RSU |
28,101 |
$0.92 |
$25.9K |
137,201 |
| 2025-01-24 |
Harvey Brian Nicholas |
Chief Financial Officer |
Retención Fiscal de RSU |
8,752 |
$0.92 |
$8.07K |
91,048 |
| 2025-01-24 |
Healey Don |
Chief Technology Officer |
Retención Fiscal de RSU |
8,560 |
$0.92 |
$7.89K |
63,769 |
| 2025-01-24 |
Aftab Blake |
Chief Scientific Officer |
Retención Fiscal de RSU |
6,270 |
$0.92 |
$5.78K |
56,241 |
| 2025-01-13 |
Maltzman Julia D. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-08-21 |
Dubin Steve |
Director |
Devolución de Acciones |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Gordon Carl L |
10 Percent Owner |
Devolución de Acciones |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Kauffman Michael |
Director |
Devolución de Acciones |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Chodakewitz Jeffrey |
Director |
Devolución de Acciones |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Sinclair Andrew |
Director |
Devolución de Acciones |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Jakobovits Aya |
Director |
Devolución de Acciones |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Peng Katie |
Director |
Devolución de Acciones |
70,200 |
$2.14 |
$150.23K |
- |
| 2024-08-19 |
Klickstein Lloyd |
Director |
Disposición |
80,000 |
$2.14 |
$171.2K |
- |
| 2024-08-19 |
Klickstein Lloyd |
Director |
Concesión de RSU |
70,200 |
$1.55 |
$108.81K |
70,200 |
| 2024-06-05 |
Dubin Steve |
Director |
Concesión de RSU |
5,900 |
- |
- |
16,800 |
| 2024-06-05 |
Gordon Carl L |
10 Percent Owner |
Concesión de RSU |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Schor Chen |
President & CEO |
Concesión de RSU |
1,770,427 |
$2.53 |
$4.48M |
1,770,427 |
| 2024-06-05 |
Kauffman Michael |
Director |
Venta Informativa |
5,900 |
$1.43 |
$8.44K |
5,900 |
| 2024-06-05 |
Harvey Brian Nicholas |
Chief Financial Officer |
Concesión de RSU |
374,829 |
$2.53 |
$948.32K |
374,829 |
| 2024-06-05 |
Chodakewitz Jeffrey |
Director |
Concesión de RSU |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Healey Don |
Chief Technology Officer |
Concesión de RSU |
271,595 |
$2.53 |
$687.14K |
271,595 |
| 2024-06-05 |
Sinclair Andrew |
Director |
Concesión de RSU |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Jakobovits Aya |
Director |
Concesión de RSU |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Galimi Francesco |
SVP & Chief Medical Officer |
Concesión de RSU |
375,077 |
$2.53 |
$948.94K |
375,077 |
| 2024-06-05 |
Aftab Blake |
Chief Scientific Officer |
Concesión de RSU |
336,911 |
$2.53 |
$852.38K |
336,911 |
| 2024-06-05 |
Peng Katie |
Director |
Concesión de RSU |
5,900 |
- |
- |
5,900 |
| 2024-01-25 |
Orbimed Advisors Llc |
10 Percent Owner |
Compra Informativa |
242,200 |
$2.40 |
$581.28K |
990,254 |
| 2024-01-25 |
Gordon Carl L |
10 Percent Owner |
Compra Informativa |
242,200 |
$2.40 |
$581.28K |
990,254 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
